Oak Street Health Inc. Stock News

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI ) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS ) rose 73.3% to $0.7971 after declining around 9% on Monday. iQIYI, Inc. (NASDAQ: IQ ) shares gained 33.5% to $5.53 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion. Oak Street Health Inc (NYSE: OSH ) gained 29.3% to $$22.65. Oak Street reported FY21 revenue of $1.43 billion. UserTesting, Inc. (NYSE: USER ) shares gained 26.2% to $10.50 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY22 EPS and sales guidance above analysts’ estimates. Veritiv Corporation (NYSE: VRTV ) gained 22.9% to $131.73 after the company posted upbeat quarterly results. Danimer Scientific Inc (NASDAQ: DNMR ) climbed 22.1% to $$4.86 following narrower-than-expected quarterly loss. LivePerson, Inc. (NASDAQ: LPSN ) gained 19.9% to $24.31. Starboard Value raised its stake in LivePerson from 8.5% to 9.7%.

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI ) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS ) rose 73.3% to $0.7971 after declining around 9% on Monday. iQIYI, Inc. (NASDAQ: IQ ) shares gained 33.5% to $5.53 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion. Oak Street Health Inc (NYSE: OSH ) gained 29.3% to $$22.65. Oak Street reported FY21 revenue of $1.43 billion. UserTesting, Inc. (NYSE: USER ) shares gained 26.2% to $10.50 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY22 EPS and sales guidance above analysts’ estimates. Veritiv Corporation (NYSE: VRTV ) gained 22.9% to $131.73 after the company posted upbeat quarterly results. Danimer Scientific Inc (NASDAQ: DNMR ) climbed 22.1% to $$4.86 following narrower-than-expected quarterly loss. LivePerson, Inc. (NASDAQ: LPSN ) gained 19.9% to $24.31. Starboard Value raised its stake in LivePerson from 8.5% to 9.7%.

Despite a loss of more than two-thirds of value over the past 12 months, Oak Street Health <> has added more than a quarter of value in morning hours on Tuesday after the…

CTI BioPharma CTIC +40%. Oak Street Health (OSH) +23%. AVITA Medical (RCEL) +15%. GoodRx Holdings GDRX -40%. Semler Scientific (SMLR) -30%.

Oak Street Health, Inc. (OSH) CEO Michael Pykosz on Q4 2021 Results - Earnings Call Transcript

The Oak Street Health Inc (NYSE: OSH) stock increased by over 25% during intraday trading today. This is why.

Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of -5.08% and 2.23%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc

NEW YORK, Feb. 28, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Oak Street Health, Inc. (NYSE: OSH) between August 6, 2020 and November 8, 2021, inclusive (the "Class Period"), of the important March 14, 2022 lead…

Oak Street Health press release (NYSE:OSH): Q4 GAAP EPS of -$0.62 misses by $0.03.Revenue of $394.1M (+58.5% Y/Y) beats by $4.31M.

CHICAGO--(BUSINESS WIRE)--Oak Street Health, Inc. (NYSE: OSH, or the “Company”), a network of value-based primary care centers for adults on Medicare, today reported financial results for its fiscal year ended December 31, 2021. “We reported a strong quarter with results favorable to the high end of guidance across metrics. These results were thanks to the hard work and dedication of our team allowing Oak Street to navigate through a challenging operating environment, including the Omicron Covi

SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Oak Street Health, Inc. (NYSE: OSH ) investors with significant losses to submit your losses now . A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: Aug. 6, 2020 – Nov. 8, 2021 Lead Plaintiff Deadline: Mar. 11, 2022 Visit: www.hbsslaw.com/investor-fraud/OSH Contact An Attorney Now: [email protected] 844-916-0895 Oak Street Health, Inc. (OSH) Securities Class Action: The lawsuit focuses on defendants'' repeated statements about Oak Street''s purported "innovative community outreach approach" to engage Medicare eligible patients and repeated claims that its "strong" at- risk patient and revenue growth are largely the product of its internal sales and marketing efforts. According to the complaint, defendants misled investors by failing to disclose that: (1) Oak Street maintained relationships with third-party … Full story available on Benzinga.com

SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Oak Street Health, Inc. (NYSE: OSH) investors with significant losses to submit your losses now . A securities fraud class action has been filed and certain investors may have valuable claims.

The Gross Law Firm issues the following notice on behalf of shareholders of Oak Street Health, Inc.. Shareholders who purchased shares of OSH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as […]

Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, recently disclosed the firm's 13F portfolio changes for the fourth quarter of 2021, which ended on Dec. 31.